Clinical Trial Update: A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating the safety and efficacy of PerioSept as an adjunct to SRP in periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• PerioSept

Snippet

Sponsor: Geistlich Pharma AG | Conditions: Periodontitis | Phase 1, Phase 2 | Status: COMPLETED